Dr. Daniela Drago is an Associate Professor and the Director of Regulatory Affairs at George Washington University’s School of Medicine and Health Sciences. She has expertise in the development of new molecular entities in multiple rare and common diseases, including oncology, ophthalmology, infectious diseases, cardiovascular, and neuroscience. Before joining academia, she held senior positions in global regulatory and medical affairs at F. Hoffman-La Roche, Vifor Pharma, Reckitt Benckiser, and Bausch & Lomb. Dr. Drago has prepared and evaluated hundreds of global regulatory submissions and participated in many meetings with regulatory agencies. Her work intersects policy issues, education, and innovation. Her current research interests focus on optimizing the development of healthcare products and advancing regulatory science. She published several articles and received multiple awards in recognition for her dedication to the regulatory field. She serves on the board of directors of the Association of Graduate Regulatory Educators and the Regulatory Affairs Certification Board. She received her Ph.D. in chemistry from the Swiss Federal Institute of Technology (ETH Zurich).